Dimerix Limited logo

Dimerix Limited

ASX:DXB.AX

Overview | Financials
Company Name Dimerix Limited
Symbol DXB.AX
Currency AUD
Price 0.38
Market Cap 209,258,780
Dividend Yield 0%
52-week-range 0.061 - 0.665
Industry Biotechnology
Sector Healthcare
CEO Dr. Nina Webster B.Sc., M.B.A., M.IP.Law, MBA, Ph.D.
Website https://dimerix.com

An error occurred while fetching data.

About Dimerix Limited

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive

Related Stocks

Pharmaxis Ltd logo

Pharmaxis Ltd

PXS.AX

0.028 AUD

Imagion Biosystems Limited logo

Imagion Biosystems Limited

IBX.AX

0.023 AUD

Patrys Limited logo

Patrys Limited

PAB.AX

0.007 AUD

PainChek Limited logo

PainChek Limited

PCK.AX

0.032 AUD

Vectus Biosystems Limited logo

Vectus Biosystems Limited

VBS.AX

0.08 AUD

Imricor Medical Systems, Inc. logo

Imricor Medical Systems, Inc.

IMR.AX

0.495 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD